Voiant is the industry leading AI-based clinical trial imaging solution provider with unparalleled scientific and clinical domain expertise, providing biopharmaceutical companies with high-speed delivery of quality clinical endpoint data. Voiant combines leadership in artificial intelligence and visionary computing, key opinion leaders for strategic therapeutic areas alignment, and clinical research experts to deliver operational excellence and consistent execution – providing the shortest path to the highest quality imaging data for clinical trials. Voiant has interpreted +1 billion images from over 700 global clinical trials, aiding numerous biopharmaceutical companies bringing new treatments to patients across oncology, respiratory, ophthalmology, cardiovascular, gastrointestinal, and liver disease domains. Voiant Hub is our built for purpose AI-powered platform, enabling us to manage the entire clinical imaging process while providing site management, as well as full transparency to sponsors every step of the way from image upload, quality control, read & analysis to delivering high quality clinical imaging endpoints.
VO-CRO
The Vanderbilt Ophthalmic Contract Research Organization (VO-CRO) is a research enterprise dedicated to facilitating our clients’ drug development efforts by producing the highest quality pre-clinical data in a timely manner. VO-CRO’s scientists have a combined 125+ years of experience, specializing in animal models of human eye disease, along with expertise in molecular-, cell-, and tissue-based approaches.
Vision Share
Vision Share is a is a non-profit member organization of U.S. Eye Banks, and a Trusted Source for Corneal Transplant and Research Tissue. Vision Share facilitates the distribution and client support of donor corneas and research tissue across the United States and in over 30 countries around the world. All Vision Share eye bank members are accredited by the EBAA and registered FDA. Types of research ocular tissue our members can provide: • Research Corneas • Long Term Preserved Corneas • Whole Globes • Sclera • Retina • Choroid • AMD • Amniotic Membrane • Normal and Disease Specific Ocular Tissue • Pterygium • Other Surgical Tissue and Bio-fluids We are also able to provide many types of microscopy and molecular biology services including: • Retinal Explant Culture • Retinal Dissection • RNA Isolation • FFPE and Cryostat Ocular Blocks and Staining • Florescence and Bright Field Imaging • 3D OCX Imaging For more capabilities visit visionshare.org/ocular-tissue-supply-for-research | Vision Share is a non-profit member organization of U.S. Eye Banks. We distribute donor corneas and research tissue globally. All Vision Share eye bank members are accredited by the Eye Bank Association of America (EBAA) and registered with the Food and Drug Administration (FDA).
Virscio, Inc.
Virscio is uniquely positioned to support nonhuman primate (NHP) ophthalmic development programs through expertly designed in vivo studies and high-quality, integrated histopathology, image analysis, and molecular assays. Our team includes board-certified ophthalmologists, pathologists and PhD scientists with deep expertise in ocular biology, disease modeling, and translational research, enabling design and execution of the optimal studies for critical development needs. Integration of in vivo ophthalmic assessments and histopathology accelerates and enhances interpretations to achieve detailed tissue pharmacodynamic and safety assessments. Specializing in ocular tissues, we offer standalone histopathology and image analysis to support analysis of primate and non-primate specimens from other testing facilities. Virscio partners closely with sponsors across early feasibility and IND-enabling programs to deliver robust data in support of successful advance to clinic.
TFS HealthScience
TFS specializes in ophthalmology clinical trials, providing comprehensive support to navigate regulatory complexities, imaging requirements, and patient recruitment challenges unique to this field. Our cross-functional teams, spanning retinal diseases, corneal disorders, glaucoma, ocular inflammation, and ophthalmic rare diseases, bring extensive therapeutic expertise with global regulatory knowledge to accelerate the development of vision-saving treatments worldwide. With a proven track record in ophthalmology drug and device development, we empower sponsors to streamline trial operations, enhance patient engagement, and ensure regulatory compliance across different regions. Whether conducting gene therapy trials for inherited retinal diseases, targeted therapies for glaucoma, or ophthalmic device studies, our full-service ophthalmology CRO solutions ensure efficient execution at every stage. Connect with an expert today! https://tfscro.com/request-proposal/
Syneos Health
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, commercial and real world insights into outcomes to address modern market realities. We bring together a talented team of professionals with a deep understanding of patient and physician behaviors and market dynamics. Together we share diverse insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. Syneos Health is powered by an authentic, inclusive and high-performance culture that cares for colleagues, customers, patients, communities and the environment. Learn more about how our expert team members can help accelerate your success. Visit syneoshealth.com.
StageBio
StageBio is dedicated exclusively to histopathology and comprehensive sample management. As The Histopathology CRO, we partner with pharmaceutical, biotechnology, and medical device sponsors to deliver high-quality GLP and non-GLP pathology support along with secure archiving and biorepository solutions from early discovery through regulatory submission. With thousands of studies successfully completed, we combine scientific rigor, operational excellence, and responsive collaboration to keep your programs moving forward with confidence.